GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » EV-to-FCF

Incanthera (AQSE:INC) EV-to-FCF : -35.45 (As of May. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Incanthera's Enterprise Value is £10.32 Mil. Incanthera's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.29 Mil. Therefore, Incanthera's EV-to-FCF for today is -35.45.

The historical rank and industry rank for Incanthera's EV-to-FCF or its related term are showing as below:

AQSE:INC' s EV-to-FCF Range Over the Past 10 Years
Min: -40.8   Med: 0   Max: 0
Current: -35.45

AQSE:INC's EV-to-FCF is ranked worse than
100% of 367 companies
in the Biotechnology industry
Industry Median: 9.77 vs AQSE:INC: -35.45

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Incanthera's stock price is £0.19. Incanthera's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.019. Therefore, Incanthera's PE Ratio for today is At Loss.


Incanthera EV-to-FCF Historical Data

The historical data trend for Incanthera's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera EV-to-FCF Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EV-to-FCF
-12.95 -11.04 -7.44 -11.33

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-FCF Get a 7-Day Free Trial - -7.44 - -11.33 -

Competitive Comparison of Incanthera's EV-to-FCF

For the Biotechnology subindustry, Incanthera's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incanthera's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Incanthera's EV-to-FCF falls into.



Incanthera EV-to-FCF Calculation

Incanthera's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10.316/-0.291
=-35.45

Incanthera's current Enterprise Value is £10.32 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Incanthera's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera  (AQSE:INC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Incanthera's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.19/-0.019
=At Loss

Incanthera's share price for today is £0.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Incanthera's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.019.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Incanthera EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Incanthera's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera (AQSE:INC) Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines